Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Neoleukin Therapeutics Inc (NQ: NLTX )

0.6200 +0.0299 (+5.07%)
Streaming Delayed Price Updated: 3:59 PM EST, Feb 6, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 139,104
Open 0.6290
Bid (Size) 0.6114 (7)
Ask (Size) 0.6390 (50)
Prev. Close 0.5901
Today's Range 0.5900 - 0.6532
52wk Range 0.3750 - 3.400
Shares Outstanding 42,425,071
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Neoleukin Therapeutics Presents Preclinical Data on NEO-TRA1 at American Society of Hematology (ASH) Annual Meeting
Targeted, precision-tuned agonist of IL-2 receptor selectively expands regulatory T cells 
From Neoleukin Therapeutics, Inc.
Via Globe NewsWire
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 70 companies set new 52-week lows. 
Via Benzinga

Performance

YTD
+22.77%
+22.77%
1 Month
+12.30%
+12.30%
3 Month
+14.01%
+14.01%
6 Month
-41.51%
-41.51%
1 Year
-81.10%
-81.10%

More News

Read More
Neoleukin Pauses Development Of NL-201, Cuts 40% Of Employee Strength
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
5 Analysts Have This to Say About Neoleukin Therapeutics
Via Benzinga
Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday
Via Benzinga
Pinterest To $23? Plus This Analyst Slashes PT On Neoleukin Therapeutics By More Than 90%
Via Benzinga
Intellia Therapeutics To Rally Around 143%? Plus Stifel Cuts PT On This Stock By 94%
Via Benzinga
Neoleukin Therapeutics Announces Third Quarter 2022 Financial Results and Corporate Update
From Neoleukin Therapeutics, Inc.
Via Globe NewsWire
Neoleukin Therapeutics Announces Oral Presentation at 64th American Society of Hematology (ASH) Annual Meeting
From Neoleukin Therapeutics, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2022
Via Benzinga
HC Wainwright Cuts Price Target On This Stock By 73%, Also Check Out Other Major PT Changes Here
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Is Toast Trading Higher By 20%: Here Are 34 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Recap: Neoleukin Therapeutics Q2 Earnings
Via Benzinga
Neoleukin Therapeutics Earnings Preview
Via Benzinga
Neoleukin Therapeutics to Host Second Quarter 2022 Financial Results Conference Call and Webcast on August 9, 2022
From Neoleukin Therapeutics, Inc.
Via Globe NewsWire
6 Penny Stocks With 1,000% Upside Potential
Via InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
68 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.